ClinicalTrials.gov
public full text
Public Domain
P.Vivax Treatment Trial
This study aims to determine whether a 14 day course of 0.5 mg/kg/day primaquine can eliminate subclinical P. vivax infections detected by high volume ultra-sensitive PCR (uPCR).
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- IMPROV (Improving the Radical Cure of Vivax Malaria)#884241
- ArterX Safety and Efficacy Study for Cardiac Indications#1245905
- Efficacy of Sildenafil on the Morbi-mortality of Peripheral Arterial Diseased Patients With Intermittent Claudication#828527
- Safety Study of Kudiezi(Yueanxin,a Chinese Medicine Injection)Used in Hospitals in China#856446
- Gram-Negative Bloodstream Infection Oral Antibiotic Therapy Trial#903466
Record · ID 1323028
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive